Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Inherent Biosciences
With
Yale University
Boston IVF
Shady Grove Fertility
University of Washington
Brigham Young University
Male Fertility and Sexual Medicine Specialists
Inception Fertility Research Institute, LLC
This prospective study will consist of analyzing a man's semen sample to determine the patient's SpermQT score and following the success of each fertility treatment to produce a pregnancy and live birth. Physicians and patients will be blinded to SpermQT results.
Age
18–45
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
The subjects have been recommended to pursue IUI, or they have recently completed an IUI (regardless of outcome)
Male partner is under 45 years of age
Female partner is under 38 years of age
The total motile sperm count from the raw semen analysis must be greater than or equal to 10 million
You may not be if
The female or male partner have a BMI equal to or greater than 40
The male partner has undergone male testosterone replacement therapy in the last 6 months
Either the female or male partner have a history of recurrent pregnancy loss, defined as 2 or more consecutive clinical/ultrasound pregnancy losses
There are any known factors contributing to female factor infertility, such as but not limited to:
Severe Endometriosis (stage 3 or higher, endometrioma on ovaries)
Multiple uterine fibroids 5cm or larger
Severe Asherman's Syndrome
Severe Mullerian anomaly
Lack of tubal patency in at least one fallopian tubes
